<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
  xmlns:dc="http://purl.org/dc/elements/1.1/"
  xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>National Health Underwriters — Health News</title>
    <link>https://nationalhealthunderwriters.com/health-news/</link>
    <description>Sector news category — verified health events only (FDA, guidelines, major studies)</description>
    <language>en-US</language>
    <lastBuildDate>Tue, 01 Sep 2026 04:29:48 GMT</lastBuildDate>
    <atom:link href="https://nationalhealthunderwriters.com/health-news/feed.xml" rel="self" type="application/rss+xml" />
    <category>Health News</category>
    <item>
      <title>FDA Approved Orzeyful, Replacing What Narcolepsy Type 1 Patients Lack</title>
      <link>https://nationalhealthunderwriters.com/health-news/fda-orzeyful-oveporexton-narcolepsy/</link>
      <guid isPermaLink="true">https://nationalhealthunderwriters.com/health-news/fda-orzeyful-oveporexton-narcolepsy/</guid>
      <description><![CDATA[FDA approved Orzeyful (oveporexton) on August 5, 2026 for narcolepsy type 1. The orexin receptor agonist class explained: mechanism, trials, access.]]></description>
      <pubDate>Mon, 10 Aug 2026 04:00:00 GMT</pubDate>
      <dc:creator>Grace Mensah</dc:creator>
      <category>Health News</category>
      <enclosure url="https://nyc3.digitaloceanspaces.com/vuga/articles/images/f9babbdc5bdea2249c4d070c/1200w.webp" type="image/jpeg" length="0" />
    </item>
    <item>
      <title>FDA Approved Lipfendra, the First Oral PCSK9 Inhibitor, for High LDL</title>
      <link>https://nationalhealthunderwriters.com/health-news/fda-lipfendra-enlicitide-oral-ldl-cholesterol/</link>
      <guid isPermaLink="true">https://nationalhealthunderwriters.com/health-news/fda-lipfendra-enlicitide-oral-ldl-cholesterol/</guid>
      <description><![CDATA[FDA approved Lipfendra (enlicitide) on July 15, 2026 — the first oral PCSK9 inhibitor. How it compares with injectables and what coverage will decide.]]></description>
      <pubDate>Sat, 18 Jul 2026 04:00:00 GMT</pubDate>
      <dc:creator>Grace Mensah</dc:creator>
      <category>Health News</category>
      <enclosure url="https://nyc3.digitaloceanspaces.com/vuga/articles/images/e32650770184aea452248403/1200w.webp" type="image/jpeg" length="0" />
    </item>
    <item>
      <title>FDA Approved Utebzi, the First Oral Carbapenem, for Complicated UTIs</title>
      <link>https://nationalhealthunderwriters.com/health-news/fda-utebzi-tebipenem-oral-uti-antibiotic/</link>
      <guid isPermaLink="true">https://nationalhealthunderwriters.com/health-news/fda-utebzi-tebipenem-oral-uti-antibiotic/</guid>
      <description><![CDATA[FDA approved Utebzi (tebipenem) June 17, 2026 for complicated UTIs. The first oral carbapenem: what ESBL resistance means for patients.]]></description>
      <pubDate>Fri, 26 Jun 2026 04:00:00 GMT</pubDate>
      <dc:creator>Grace Mensah</dc:creator>
      <category>Health News</category>
      <enclosure url="https://nyc3.digitaloceanspaces.com/vuga/articles/images/9d2ab19bf448fc5e8010f170/1200w.webp" type="image/jpeg" length="0" />
    </item>
    <item>
      <title>FDA Approved Hepcludex, Closing the US Gap in Hepatitis D Treatment</title>
      <link>https://nationalhealthunderwriters.com/health-news/fda-hepcludex-hepatitis-d-approval/</link>
      <guid isPermaLink="true">https://nationalhealthunderwriters.com/health-news/fda-hepcludex-hepatitis-d-approval/</guid>
      <description><![CDATA[FDA approved Hepcludex (bulevirtide) May 22, 2026 for chronic hepatitis delta. What coinfection with hepatitis B means and who should get tested.]]></description>
      <pubDate>Wed, 03 Jun 2026 04:00:00 GMT</pubDate>
      <dc:creator>Grace Mensah</dc:creator>
      <category>Health News</category>
      <enclosure url="https://nyc3.digitaloceanspaces.com/vuga/articles/images/afe74fb8ef41ac587ae211fd/1200w.webp" type="image/jpeg" length="0" />
    </item>
    <item>
      <title>FDA Approved Veppanu for the Mutation That Ends Hormone Therapy&apos;s Run</title>
      <link>https://nationalhealthunderwriters.com/health-news/fda-veppanu-epdegestrant-breast-cancer/</link>
      <guid isPermaLink="true">https://nationalhealthunderwriters.com/health-news/fda-veppanu-epdegestrant-breast-cancer/</guid>
      <description><![CDATA[FDA approved Veppanu (epdegestrant) on May 1, 2026 for ESR1-mutated metastatic breast cancer. How the oral receptor degrader fits the treatment sequence.]]></description>
      <pubDate>Mon, 11 May 2026 04:00:00 GMT</pubDate>
      <dc:creator>Grace Mensah</dc:creator>
      <category>Health News</category>
      <enclosure url="https://nyc3.digitaloceanspaces.com/vuga/articles/images/8d9144187ba7c5ab857b8170/1200w.webp" type="image/jpeg" length="0" />
    </item>
    <item>
      <title>FDA Approved Foundayo: the Oral GLP-1 That Rewrites Obesity Drug Economics</title>
      <link>https://nationalhealthunderwriters.com/health-news/fda-foundayo-orforglipron-oral-glp1/</link>
      <guid isPermaLink="true">https://nationalhealthunderwriters.com/health-news/fda-foundayo-orforglipron-oral-glp1/</guid>
      <description><![CDATA[FDA approved Foundayo (orforglipron) on April 1, 2026 — the oral GLP-1 for weight management. What trial numbers show and whether insurance will cover it.]]></description>
      <pubDate>Sun, 19 Apr 2026 04:00:00 GMT</pubDate>
      <dc:creator>Grace Mensah</dc:creator>
      <category>Health News</category>
      <enclosure url="https://nyc3.digitaloceanspaces.com/vuga/articles/images/8e2896d9264a5d424edc7210/1200w.webp" type="image/jpeg" length="0" />
    </item>
    <item>
      <title>FDA Approved Icotyde, Taking the Top Psoriasis Target From Injection to Pill</title>
      <link>https://nationalhealthunderwriters.com/health-news/fda-icotyde-icotrokinra-psoriasis-approval/</link>
      <guid isPermaLink="true">https://nationalhealthunderwriters.com/health-news/fda-icotyde-icotrokinra-psoriasis-approval/</guid>
      <description><![CDATA[FDA approved Icotyde (icotrokinra) on March 17, 2026 for plaque psoriasis. The first oral IL-23 pathway option: how it compares with injected biologics.]]></description>
      <pubDate>Fri, 27 Mar 2026 04:00:00 GMT</pubDate>
      <dc:creator>Grace Mensah</dc:creator>
      <category>Health News</category>
      <enclosure url="https://nyc3.digitaloceanspaces.com/vuga/articles/images/8f9966eb7c8995d162b82970/1200w.webp" type="image/jpeg" length="0" />
    </item>
    <item>
      <title>FDA Approved Bysanti: a New Antipsychotic for Schizophrenia and Bipolar I</title>
      <link>https://nationalhealthunderwriters.com/health-news/fda-bysanti-milsaperidone-approval/</link>
      <guid isPermaLink="true">https://nationalhealthunderwriters.com/health-news/fda-bysanti-milsaperidone-approval/</guid>
      <description><![CDATA[FDA approved Bysanti (milsaperidone) on February 20, 2026 for schizophrenia and bipolar I manic episodes. How a new atypical antipsychotic fits care and…]]></description>
      <pubDate>Wed, 04 Mar 2026 05:00:00 GMT</pubDate>
      <dc:creator>Grace Mensah</dc:creator>
      <category>Health News</category>
      <enclosure url="https://nyc3.digitaloceanspaces.com/vuga/articles/images/74ed3f4522ec37e021282530/1200w.webp" type="image/jpeg" length="0" />
    </item>
    <item>
      <title>CDC Moves to Align the Childhood Vaccine Schedule With Other Countries</title>
      <link>https://nationalhealthunderwriters.com/health-news/cdc-childhood-immunization-schedule-update-2026/</link>
      <guid isPermaLink="true">https://nationalhealthunderwriters.com/health-news/cdc-childhood-immunization-schedule-update-2026/</guid>
      <description><![CDATA[CDC announced childhood immunization schedule changes on January 5, 2026. How US and international schedules compare, and what parents should do meanwhile.]]></description>
      <pubDate>Tue, 10 Feb 2026 05:00:00 GMT</pubDate>
      <dc:creator>Grace Mensah</dc:creator>
      <category>Health News</category>
      <enclosure url="https://nyc3.digitaloceanspaces.com/vuga/articles/images/47861393adf3b40c4da7dec6/1200w.webp" type="image/jpeg" length="0" />
    </item>
    <item>
      <title>FDA Approved Zycubo, the First Copper Therapy Cleared for Menkes Disease</title>
      <link>https://nationalhealthunderwriters.com/health-news/fda-zycubo-copper-histidinate-menkes/</link>
      <guid isPermaLink="true">https://nationalhealthunderwriters.com/health-news/fda-zycubo-copper-histidinate-menkes/</guid>
      <description><![CDATA[FDA approved Zycubo (copper histidinate) January 12, 2026 for Menkes disease. What the rare copper-transport disorder is and why this matters.]]></description>
      <pubDate>Sun, 18 Jan 2026 05:00:00 GMT</pubDate>
      <dc:creator>Grace Mensah</dc:creator>
      <category>Health News</category>
      <enclosure url="https://nyc3.digitaloceanspaces.com/vuga/articles/images/b4e42ed000053b0f825272dd/1200w.webp" type="image/jpeg" length="0" />
    </item>
  </channel>
</rss>